News

Dispex members can login here to see the updates all together in one place, and in alphabetical order.   Looking to join Dispex, please click here.

  Our new guide, the Essential Guide for Dispensary Managers is an invaluable resource for anyone involved in managing a dispensary. Written by Kirstye, an experienced Dispensary Manager and Dispex...

  Join us for a lunchtime webinar as we tackle the ongoing financial challenges facing dispensing doctors. This session will be packed with practical strategies to help your practice navigate...

Source: Chemist and Druggist 2.1.25 “The government is working towards introducing legislation to enable hub-and-spoke dispensing between different legal entities in 2025,” pharmacy minister Stephen Kinnock last week (December 23)...

Reclassification of Nexplanon as “Attracts an Administration Fee” only comes into force on 1st January 2025. New direction in section 2.2.Citation, commencement, extent, application and interpretation (3) Directions 2(2)(b) comes...

Source: MHRA / Gov.uk 13.1.25 Jubilant Pharmaceuticals NV has informed the MHRA that the Patient information leaflet (PIL) in the cartons for the batches listed in this notification include an...

Source: NHSBSA/SPS Name of SSP \ ref no. Start and end date Supporting guidance SSP081 Estradot® 100 microgram patches (PDF:215KB) 19 December 2024 to 28 January 2025 Estradot® 100 microgram patches supporting guidance...

Source: Practicce Index Earlier this week, the Government laid out its new ‘elective reform plan’, which aims to cut the list of patients waiting more than 18 weeks for NHS...

We’re taking flexibility to the next level with our bite-sized educational videos! We understand how busy practices are, so we’ve created flexible, bite-sized videos to fit your busy schedules. Our...

Source: NHS England Bulletin 9.1.25 New asthma guidelines have been published by NICE/BTS/SIGN. These new clinical guidelines include significant changes in inhaler prescribing practices, for example the move away from...

Source: MHRA 9.1.25 Bristol Laboratories Limited has informed the MHRA that the Patient Information Leaflet (PIL) in the batches in the table for Rabeprazole sodium 10mg and 20mg gastro-resistant tablets...

The Essential Dispensary Manager’s guid Our Essential Dispensary Manager’s guide is exactly what you need! Unlike other resources, this guide doesn’t just tell you the why – it shows you...